UA-021

N/A

Report date: 2026/05/12 20:00:17
NME

Base Information

Drug NameUA-021
Drug Alias NameUA-021
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase 2 inhibitorsProtein allosteric inhibitors
TargetsTyrosine-protein kinase 2
Therapy Area/IndicationsPsoriasisLupus NephritisCrohn Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesYousen Jianheng Biomedical (Shanghai) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesYousen Jianheng Biomedical (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsPsoriasisLupus NephritisCrohn Disease +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A